Institutional investors purchased a net $354.0 thousand shares of BPAX during the quarter ended December 2012 and now own 10.67% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
| Other institutional | 7.93% |
| Mutual fund holders | 2.74% |
| Individual stakeholders | -- |